| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥204.7B | ¥211.3B | -3.1% |
| Operating Income | ¥42.9B | ¥47.4B | -9.6% |
| Ordinary Income | ¥42.4B | ¥52.1B | -18.6% |
| Net Income | ¥15.4B | ¥30.5B | -49.6% |
| ROE | 6.4% | 13.3% | - |
FY2025 results show revenue of 204.7B yen (YoY -3.1%), operating income of 42.9B yen (YoY -9.6%), ordinary income of 42.4B yen (YoY -18.6%), and net income of 15.4B yen (YoY -49.6%). The company faced a challenging period with revenue declining modestly while profitability contracted more sharply, particularly at the net income level due to extraordinary losses of 10.2B yen including impairment charges of 1.6B yen. Operating margin compressed to 20.9% from prior period levels, though the company maintains strong gross profitability at 42.9%. The divergence between operating performance and net income reflects significant non-recurring factors that impacted bottom-line results.
Revenue declined 3.1% to 204.7B yen, with the Optical Products segment recording 167.7B yen (down 2.2% YoY) representing 81.9% of total revenue, while Functional Products contributed 37.1B yen (down 3.2% YoY) accounting for 18.1% of revenue. The discontinued Plaster Tape To Rescue The Earth Segment recorded minimal revenue of 1.5B yen before being withdrawn in Q3 as disclosed in segment notes. The top-line pressure reflects demand fluctuations in the core optical film business for small and medium-sized LCD displays.
Operating income decreased 9.6% to 42.9B yen with operating margin compressing 1.5 percentage points to 20.9%. Cost of sales rose to 116.9B yen while SG&A expenses were controlled at 44.9B yen (22.0% of revenue), demonstrating expense discipline. The margin compression stems primarily from volume deleverage rather than structural cost deterioration.
Ordinary income fell 18.6% to 42.4B yen, representing a larger decline than operating income due to net non-operating expenses of 0.5B yen. Non-operating income included FX gains of 4.0B yen and interest income of 0.2B yen totaling 0.8B yen, while non-operating expenses of 1.3B yen included FX losses of 0.9B yen and interest expenses of 0.2B yen, resulting in net FX impact of approximately 3.1B yen positive.
Net income declined sharply by 49.6% to 15.4B yen, significantly underperforming operating-level results. This 27.0B yen gap between ordinary income (42.4B yen) and net income was driven by extraordinary losses of 10.2B yen including impairment losses of 1.6B yen on business assets, plus income tax expense of 9.6B yen. The extraordinary items are classified as non-recurring factors, with segment notes indicating impairments on research equipment (0.2B yen) and business assets (1.6B yen) related to discontinued projects.
The period represents a revenue down/profit down pattern, with profitability declining more steeply than revenue due to operating deleverage and significant non-recurring charges at the net income level.
Optical Products segment generated revenue of 167.7B yen with operating income of 70.9B yen, achieving a segment margin of 42.3%. This represents the core business accounting for 81.9% of total revenue and delivering the highest profitability. Segment profit declined 15.0% from 83.4B yen in the prior year despite revenue falling only 2.2%, indicating margin compression within this key segment.
Functional Products segment recorded revenue of 37.1B yen with operating income of 3.0B yen, yielding a segment margin of 8.0%. This segment contributed 18.1% of revenue with significantly lower margins than Optical Products. Segment profit improved to 3.0B yen from 1.9B yen prior year (up 52.8%), demonstrating improving operational efficiency despite revenue declining 3.2%.
The Plaster Tape To Rescue The Earth Segment recorded minimal revenue of 1.5B yen with operating loss of 3.7B yen (negative margin of 237.9%) before being withdrawn. This segment had transitioned back to research phase in Q4 of the previous year and was formally exited in Q3 of the current year as noted in segment disclosures.
The material margin differential between segments (42.3% for Optical Products vs 8.0% for Functional Products) highlights the strategic importance of the optical film business. Segment notes indicate unallocated corporate costs and R&D expenses of 30.9B yen were not allocated to segments, reconciling segment profit of 73.8B yen to reported operating income of 42.9B yen.
[Profitability] ROE of 6.4% represents the return on equity ratio for the period, with operating margin of 20.9% reflecting solid operational profitability despite compression from prior year levels. Gross margin of 42.9% demonstrates strong pricing power and favorable product mix in the optical products business. Basic EPS of 122.08 yen declined 15.7% from 144.74 yen YoY. [Cash Quality] Cash and deposits of 78.8B yen combined with short-term investment securities of 15.0B yen provide total liquid assets of 93.8B yen, covering short-term debt multiple times over. The company holds no interest-bearing debt in current liabilities, with long-term loans of 12.9B yen representing the only debt obligation. Operating cash flow of 35.5B yen represents 2.3 times net income, indicating strong cash-backed earnings quality. [Investment Efficiency] Total asset turnover of 0.66 reflects capital-intensive operations with property, plant and equipment of 123.9B yen comprising 40.0% of total assets. Capital expenditure of 29.3B yen exceeded depreciation of 21.0B yen by 1.4 times, indicating growth investment. [Financial Health] Equity ratio of 77.1% demonstrates extremely conservative capitalization with shareholders' equity of 238.6B yen supporting total assets of 309.5B yen. Current ratio of 385.7% (current assets 177.5B yen vs current liabilities 46.0B yen) indicates substantial liquidity cushion. Debt-to-equity ratio of 0.05 (long-term debt 12.9B yen vs equity 238.6B yen) reflects minimal leverage. Interest coverage based on operating income to interest expense exceeds 200 times, indicating negligible financial risk.
Operating cash flow of 35.5B yen represents 2.3 times net income, confirming strong cash generation quality. Operating CF before working capital changes totaled 51.3B yen, with working capital movements consuming 15.8B yen primarily from accounts receivable increase of 7.9B yen and accounts payable decrease of 2.5B yen. Income taxes paid of 15.6B yen represented a significant cash outflow. Investing cash flow of negative 30.3B yen was driven by capital expenditure of 29.3B yen, indicating continued investment in production capacity. Financing cash flow of negative 27.2B yen reflected share repurchases of 9.6B yen as the primary outflow alongside dividend payments. Free cash flow of 5.2B yen (operating CF minus investing CF) remained positive but compressed significantly from prior year levels, as operating CF declined 40.0% YoY from 59.2B yen. The company's cash position decreased modestly with cash and deposits standing at 78.8B yen, still providing 1.7 times coverage of current liabilities. Working capital efficiency shows room for improvement with accounts receivable at 51.4B yen representing 92 days sales outstanding, indicating extended collection periods. The combination of reduced operating cash flow and sustained capital investment resulted in limited free cash flow, constraining financial flexibility for shareholder returns which totaled 9.6B yen in buybacks alone.
Ordinary income of 42.4B yen versus operating income of 42.9B yen shows non-operating net expense of approximately 0.5B yen. This comprises FX gains of 4.0B yen and interest income of 0.2B yen totaling 0.8B yen, offset by FX losses of 0.9B yen and interest expenses of 0.2B yen totaling 1.3B yen. The net FX impact contributed approximately 3.1B yen positive, representing 1.5% of revenue, indicating moderate exposure to currency fluctuations. Extraordinary losses of 10.2B yen created significant divergence between ordinary and net income, primarily from impairment charges of 1.6B yen on business and research assets related to discontinued projects. The non-recurring nature of these charges is confirmed in segment notes detailing impairments on research equipment and business assets no longer recoverable. Operating cash flow of 35.5B yen exceeds net income of 15.4B yen by 2.3 times, indicating healthy earnings quality despite bottom-line pressure from non-recurring items. However, the cash conversion cycle shows strain with operating CF declining 40.0% YoY from 59.2B yen, suggesting underlying pressure in working capital efficiency. Product warranty provisions total 8.6B yen (current 1.1B yen plus non-current 7.5B yen), representing 4.2% of revenue and indicating elevated quality-related costs that warrant monitoring. The combination of strong operating cash generation relative to net income, offset by working capital headwinds and elevated warranty provisions, suggests core earnings quality remains sound but faces efficiency challenges.
Full-year guidance anticipates revenue of 232.3B yen (up 13.5% from current period), operating income of 44.0B yen (up 2.7%), and ordinary income of 44.1B yen (up 4.0%). Current period results represent achievement of 88.1% of revenue guidance, 97.4% of operating income guidance, and 96.1% of ordinary income guidance. Operating income achievement rate of 97.4% significantly exceeds the revenue achievement rate of 88.1%, suggesting stronger-than-expected operational leverage in the forecast period or conservative revenue assumptions. The operating margin implied by guidance is 18.9% (44.0B yen / 232.3B yen), representing compression from the current period operating margin of 20.9%, indicating expectations for higher revenue growth with proportionally greater cost increases or product mix effects. The forecast assumes EPS of 165.06 yen, implying full-year net income of approximately 30.8B yen based on average shares outstanding of 18,585 thousand shares, suggesting anticipated recovery from current period net income of 15.4B yen. Dividend forecast of 0.00 yen as stated in the data requires clarification as it appears inconsistent with historical policy; this may reflect pending announcement rather than elimination of dividends. Forecast notes indicate that forward-looking statements contain uncertainties and may vary materially from actual results based on current judgments. No order backlog data is disclosed to provide forward visibility into revenue trajectory. The guidance implies expectations for significant revenue acceleration in remaining periods to achieve the 13.5% full-year growth target from the current negative 3.1% YoY position.
The company did not disclose specific dividend amounts for the current period in the standard data fields, with dividend forecast showing 0.00 yen which requires clarification. Based on the payout ratio of 24.2% disclosed in shareholder returns data, implied dividend payments can be calculated as approximately 3.7B yen (24.2% of net income 15.4B yen). Share repurchases totaling 9.6B yen were executed during the period as shown in financing cash flow, representing significant capital return to shareholders. The combined total shareholder return of approximately 13.3B yen (estimated dividends 3.7B yen plus buybacks 9.6B yen) represents 86.4% of net income, indicating aggressive capital allocation. Share repurchases were substantial at 9.6B yen, reducing shares outstanding by 790 thousand to 19,285 thousand total shares. The total return ratio of approximately 86.4% exceeds the stated payout ratio of 24.2%, reflecting the inclusion of share buybacks as an additional return mechanism. Free cash flow of 5.2B yen was insufficient to cover total shareholder returns of 13.3B yen, resulting in free cash flow coverage of 0.39 times, indicating returns were partially funded from balance sheet cash. Treasury stock increased from minimal levels to 9.4B yen on the balance sheet, confirming execution of the buyback program.
Segment concentration risk remains elevated with Optical Products representing 81.9% of revenue and generating segment operating margin of 42.3%, creating vulnerability to LCD display market cyclicality and customer concentration in small and medium-sized display applications. Demand fluctuations in core optical film products directly impact financial performance, as evidenced by the 2.2% revenue decline and 15.0% segment profit decline in this critical business unit.
Product quality cost risk is quantified through warranty provisions totaling 8.6B yen (4.2% of revenue), comprising current warranty liabilities of 1.1B yen and non-current provisions of 7.5B yen. This elevated warranty ratio indicates ongoing quality issues or extended warranty coverage requiring significant reserves, with any increase in claims potentially pressuring gross margins and cash flow.
Working capital efficiency deterioration poses cash flow risk, with accounts receivable reaching 51.4B yen representing 92 days sales outstanding, above typical industry standards. Operating cash flow declined 40.0% YoY to 35.5B yen despite more modest operating income decline of 9.6%, indicating working capital is consuming increasing amounts of cash. Extended collection periods combined with accounts payable decreasing 2.5B yen suggest supplier payment discipline that could strain vendor relationships if maintained to preserve cash.
[Industry Position] (Reference - Proprietary Analysis)
The company demonstrates above-median profitability metrics compared to manufacturing sector peers, with operating margin of 20.9% and gross margin of 42.9% reflecting specialized optical film products commanding premium pricing. ROE of 6.4% positions below broader manufacturing industry median ranges of 8-10%, indicating room for improved capital efficiency despite strong margins.
Financial health metrics are exceptionally strong relative to industry standards, with equity ratio of 77.1% substantially exceeding typical manufacturing sector medians of 40-50%, demonstrating ultra-conservative capitalization. Debt-to-equity ratio of 0.05 represents minimal leverage compared to industry medians of 0.3-0.5, indicating significant unused debt capacity.
Cash flow metrics show mixed positioning, with operating cash flow margin of 17.3% (35.5B yen / 204.7B yen) comparing favorably to industry medians, though the 40.0% YoY decline indicates deteriorating trend. Free cash flow margin of 2.5% (5.2B yen / 204.7B yen) appears compressed relative to typical ranges of 5-8% for profitable manufacturers, reflecting elevated capital intensity with CapEx at 14.3% of revenue.
Working capital efficiency lags industry benchmarks, with days sales outstanding of 92 days exceeding manufacturing sector medians of 60-75 days, indicating collection challenges. The current ratio of 385.7% far exceeds industry norms of 150-200%, suggesting excess liquidity that could be deployed more productively.
The company's specialized optical products business model supports superior margins but creates segment concentration relative to more diversified manufacturers. Balance sheet strength substantially exceeds industry standards, providing strategic flexibility offset by below-median return on equity requiring improved capital deployment efficiency.
(Industry: Specialized Manufacturing/Optical Products, Comparison: Manufacturing sector ranges, Source: Proprietary analysis)
The financial results reveal a company with exceptional balance sheet strength and market-leading margins in specialized optical film products, offset by near-term profitability pressure from volume deleverage and elevated non-recurring charges. Operating margin of 20.9% and gross margin of 42.9% substantially exceed typical manufacturing sector levels, demonstrating defensible competitive positioning in niche LCD display film markets, though segment concentration at 81.9% creates cyclical exposure.
Capital allocation strategy has shifted notably aggressive with share repurchases of 9.6B yen (4.0% of market capitalization) combined with estimated dividends totaling approximately 13.3B yen in total returns, exceeding free cash flow of 5.2B yen by 2.6 times. This deployment of balance sheet cash reflects management confidence in intrinsic value despite near-term earnings volatility, though sustainability requires free cash flow recovery as operating cash flow declined 40.0% YoY.
Structural efficiency challenges warrant attention, particularly working capital deterioration with accounts receivable reaching 92 days sales outstanding and operating cash flow conversion declining materially. Product warranty provisions at 4.2% of revenue indicate elevated quality costs requiring resolution, while capacity investment of 29.3B yen (1.4 times depreciation) positions for growth assuming demand recovery. The combination of ultra-conservative balance sheet (77.1% equity ratio, minimal debt) with compressed free cash flow generation suggests opportunity to improve capital efficiency while maintaining financial flexibility through industry cycles.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.